Unlock instant, AI-driven research and patent intelligence for your innovation.

Benzopyridine azepines and their applications

A kind of technology of benzopyridine azepine and benzopyridine, which is applied to the application field in the preparation of antitumor compounds

Inactive Publication Date: 2015-07-29
SHANGHAI INST OF PHARMA IND CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In view of the complex pathogenesis of tumors, single inhibition of a certain signal transduction pathway can easily make tumors develop drug resistance through evasion mechanisms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzopyridine azepines and their applications
  • Benzopyridine azepines and their applications
  • Benzopyridine azepines and their applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0090] Synthesis of N-benzyl-4-chloro-3-nitro-N-phenylpyridin-2-amine (intermediate 3-1)

[0091] Take 2,4-dichloro-3-nitropyridine (1.93g, 10mmol) and K 2 CO 3 (1.66g, 12mmol) was dissolved in DMF 10mL, and N-benzylaniline (1.83g, 10mmol) in DMF solution 10mL was slowly added dropwise thereto, and the reaction was stirred at room temperature for 12h. After the reaction, 30 mL of ethyl acetate was added to dilute, washed with water (20 mL×3), diluted hydrochloric acid (1M, 10 mL), and saturated brine (20 mL), and the organic layer was dried over anhydrous sodium sulfate. After filtration and concentration, the resulting solid was recrystallized from ethanol to obtain 2.91 g of a yellow solid, with a yield of 85.6%.

[0092] ESI-MS[M+H] + :m / z 340.3

[0093] 1 H NMR (400MHz, DMSO-d 6)δppm: 8.40(d,1H,J=7Hz,pyridine-6-H),6.87~7.84(m,11H,Ar-H,pyridine-5-H),4.53(s,2H,CH 2 ).

Embodiment 2

[0095] N 2 -Benzyl-4-chloro-N 2 -Synthesis of phenylpyridine-2,3-diamine (intermediate 4-1)

[0096] Take intermediate 3-1 (3.40g, 10mmol) and dissolve it in a mixed solution of ethanol 40mL and water 10mL, add iron powder (1.68g, 30mmol) and NH 4 Cl (0.32g, 6mmol). The temperature was raised to reflux, and the reaction was stirred for 5h. After the reaction, cool to room temperature, filter through diatomaceous earth, concentrate the filtrate, add 50 mL of ethyl acetate to dilute, and wash with saturated NaHCO 3 solution, water and saturated brine, and the organic layer was dried over anhydrous sodium sulfate. After filtration and concentration, the residue was purified by silica gel column chromatography, and the developing solvent was petroleum ether: ethyl acetate (V / V, 5:1) to obtain 2.26 g of a yellow solid with a yield of 72.9%.

[0097] ESI-MS[M+H] + : m / z 310.4

[0098] 1 H NMR (400MHz, DMSO-d 6 )δppm: 8.02(d,1H,J=8Hz,pyridine-6-H),6.85~7.79(m,11H,Ar-H,pyridi...

Embodiment 3

[0100] Synthesis of N-{2-[benzyl(phenyl)amino]-4-chloro-pyridin-3-yl]formamide (intermediate 5-1)

[0101] Take 8 mL of acetic anhydride and drop it into 20 mL of formic acid solution in which Intermediate 4-1 (3.10 g, 10 mmol) is dissolved at 0°C. After the drop is complete, stir and react at 20°C for 2 h. After the reaction was completed, the solvent was evaporated to dryness, and toluene was added to the residue to remove the solvent by azeotropic evaporation. This was repeated twice to obtain 3.30 g of a white solid with a yield of 97.7%. The product does not need to be purified and can be directly used for the next reaction.

[0102] ESI-MS[M+H] + :m / z 338.7

[0103] 1 H NMR (400MHz, DMSO-d 6 )δppm: 9.17(s,1H,CHO),8.45(s,1H,N H CHO),8.11(d,1H,J=8Hz,pyridine-6-H),6.91~7.85(m,11H,Ar-H,pyridine-5-H),4.51(s,2H,CH 2 ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed are a benazepine compound and an application thereof. The benazepine compound, as a synthon for preparing a novel compound with an anti-tumor activity, results in a compound that has a significantly improved ex vivo enzyme-inhibiting activity, and shows a multi-target inhibitory effect, and thus has a notable scientific advancement and a value of in-depth research and development. The benazepine compound is a compound shown in formula (I) or a pharmaceutically acceptable salt thereof.

Description

technical field [0001] The invention relates to benzopyridine azepine compounds and the application of the compounds in the preparation of antitumor compounds. Background technique [0002] Hepatocyte growth factor (HGF), also known as discrete factor (Scatter Factor, SF), is a multifunctional cytokine that can promote the growth of various types of cells such as liver cells, epithelial cells, endothelial cells, and hematopoietic cells. growth, migration and morphogenesis. The c-Met transmembrane protein is a protein product encoded by the c-met proto-oncogene and is a high-affinity receptor for HGF. When HGF binds to its receptor c-Met, it will cause autophosphorylation of c-Met tyrosine kinase, thereby activating c-Met tyrosine kinase activity, further activating a variety of different downstream signaling molecules in cells, and inducing cell development A series of biological effects, such as cell dispersion, movement, proliferation, invasion, migration, and finally me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04C07D498/04C07D513/04A61K31/5513A61K31/553A61K31/554A61P35/00
CPCC07D471/04C07D498/04C07D513/04A61P35/00
Inventor 李建其王文雅黄道伟杜振新卢秀莲王佳静黄美花
Owner SHANGHAI INST OF PHARMA IND CO LTD